Literature DB >> 25146334

NSCLC metastasis: going with ELMO3.

Marie-Anne Goyette, Jean-François Côté1.   

Abstract

Comment on: Signe Søes, Iben Lyster Daugaard, Brita Singers Sørensen, Andreas Carus, Manuel Mattheisen, Jan Alsner, Jens Overgaard, Henrik Hager, Lise Lotte Hansen, and Lasse Sommer Kristensen. Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience. 2014; 1(5): 367-7.

Entities:  

Year:  2014        PMID： 25146334      PMCID： PMC4171597          DOI： 10.18632/oncotarget.2341

Source DB:  PubMed          Journal:  Oncotarget        ISSN： 1949-2553


  7 in total

1.  Opening up on ELMO regulation: New insights into the control of Rac signaling by the DOCK180/ELMO complex.

Authors:  Manishha Patel; Ariane Pelletier; Jean-François Côté
Journal:  Small GTPases       Date:  2011-09-01

2.  An evolutionarily conserved autoinhibitory molecular switch in ELMO proteins regulates Rac signaling.

Authors:  Manishha Patel; Yoran Margaron; Nadine Fradet; Qi Yang; Brian Wilkes; Michel Bouvier; Kay Hofmann; Jean-François Côté
Journal:  Curr Biol       Date:  2010-10-28       Impact factor: 10.834

3.  MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.

Authors:  Shilpi Arora; Aarati R Ranade; Nhan L Tran; Sara Nasser; Shravan Sridhar; Ronald L Korn; Julianna T D Ross; Harshil Dhruv; Kristen M Foss; Zita Sibenaller; Timothy Ryken; Michael B Gotway; Seungchan Kim; Glen J Weiss
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

Review 4.  Mouse models for human lung cancer.

Authors:  Ralph Meuwissen; Anton Berns
Journal:  Genes Dev       Date:  2005-03-15       Impact factor: 11.361

5.  Insights into the biological functions of Dock family guanine nucleotide exchange factors.

Authors:  Mélanie Laurin; Jean-François Côté
Journal:  Genes Dev       Date:  2014-03-15       Impact factor: 11.361

6.  Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.

Authors:  Signe Søes; Iben Lyster Daugaard; Brita Singers Sørensen; Andreas Carus; Manuel Mattheisen; Jan Alsner; Jens Overgaard; Henrik Hager; Lise Lotte Hansen; Lasse Sommer Kristensen
Journal:  Oncoscience       Date:  2014-05-23

7.  Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.

Authors:  Paola Ulivi; Giovanni Foschi; Marta Mengozzi; Emanuela Scarpi; Rosella Silvestrini; Dino Amadori; Wainer Zoli
Journal:  Int J Mol Sci       Date:  2013-05-16       Impact factor: 5.923
  7 in total
  7 in total

1.  ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.

Authors:  Lorenz Kadletz; Gregor Heiduschka; Robert Wiebringhaus; Elisabeth Gurnhofer; Ulana Kotowski; Georg Haymerle; Markus Brunner; Conor Barry; Lukas Kenner
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

2.  ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.

Authors:  Wei Fan; Haikou Yang; Hong Xue; Yong Sun; Jun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  siRNA-TMEM98 inhibits the invasion and migration of lung cancer cells.

Authors:  Ming Mao; Jiakuan Chen; Xia Li; Zhouqing Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  Knockdown of ELMO3 Suppresses Growth, Invasion and Metastasis of Colorectal Cancer.

Authors:  Hui-Yun Peng; Qiong-Fang Yu; Wei Shen; Cheng-Ming Guo; Zhen Li; Xiao-Yan Zhou; Nan-Jin Zhou; Wei-Ping Min; Dian Gao
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

5.  Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation.

Authors:  Ansheng Wang; Guixin Duan; Chengling Zhao; Yuan Gao; Xuegang Liu; Zuyi Wang; Wei Li; Kangwu Wang; Wei Wang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

6.  Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer.

Authors:  Yan Hu; Qiongfang Yu; Yao Zhong; Wei Shen; Xiaoyan Zhou; Xu Liu; Mingpu Xu; Nanjin Zhou; Weiping Min; Dian Gao
Journal:  Biomed Res Int       Date:  2018-09-24       Impact factor: 3.411

7.  ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.

Authors:  Ulana Kotowski; Lorenz Kadletz; Sven Schneider; Felicitas Oberndorfer; Boban M Erovic; Matthaeus Ch Grasl; Claudia Lill; Gregor Heiduschka
Journal:  Pathol Oncol Res       Date:  2018-10-29       Impact factor: 3.201
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.